Table 1. Demographics of Trial Participants.
Demographics | No. (%) | |
---|---|---|
ESG (nā=ā106) | CSG (nā=ā106) | |
Sex | ||
Female | 50 (47%) | 40 (38%) |
Male | 56 (53) | 66 (62) |
Gestation, mean (SD), weeks | 39.2 (1.7) | 39.2 (1.8) |
Mode of delivery | ||
Vaginal | ||
Cephalic | 32 (30.5) | 23 (21.7) |
Breech | 1 (1.0) | 2 (1.9) |
Complex | 2 (1.9) | 3 (2.8) |
Instrumental | 20 (18.9) | 28 (26.4) |
Cesarean delivery | ||
Emergency | 45 (42.9) | 45 (42.5) |
Elective | 6 (5.7) | 5 (4.7) |
Diagnostic group | ||
HIE | 78 (74) | 74 (70) |
Other | 28 (26) | 32 (30) |
Resuscitation received at birth | 78 (73.6) | 96 (90.6) |
Apgar Score, mean (SD), min | ||
1 | 2.7 (2.6) | 2.9 (2.6) |
5 | 4.6 (2.7) | 4.9 (2.5) |
Age at randomization, h | 26.7 (13.4) | 28.9 (13.7) |
Site of recruitment | ||
Victoria, Australia | 12 | 12 |
New South Wales, Australia | 12 | 14 |
Queensland, Australia | 48 | 47 |
Western Australia, Australia | 25 | 27 |
Tasmania/South Australia, Australia | 3 | 3 |
Non-Australia | 6 | 3 |
Abbreviations: CSG, clinical seizure group; ESG, electrographic seizure group.